Bill Geary
Executive Partner Advisor @ Flare Capital Partners
Boston, United States
Bill Geary is a Series B investor at Flare Capital Partners in Boston focused on Health Care and Software. Bill is a Cofounder and Partner at Flare Capital Partners, a team of proven healthcare technology venture capital investors known for delivering unparalleled strategic industry resources, insight and a total commitment to the success of the entrepreneurs with whom we have the privilege of partnering. Prior to starting Flare Capital Partners inOctober 2013 with its inaugural fund closing in April 2015, Bill was with North Bridge Venture Partners since its founding in 1994.During Bill's twenty-year tenure investing in young and emerging healthcare companies, he has served on the Boards of numerous industry-leading companies and played a critical role, actively helping and working closely with management teams. His current and prior healthcare investments include Aetion, Bright Health, ClearDATA, Curisium, HealthReveal, Valence Health (Evolent Health), VisitPay, Humedica (Optum Analytics), SynapDx, Connance, Pharmetrics (IMS Health) and eBenX (ADP). Previously, Bill was a Partner at Hambro International Equity Partners. Prior to that, he was Chief Financial Officer of MathSoft, a science and engineering applications software start-up that subsequently went public on the NASDAQ and was later acquired by Parametric Technology Corporation [NASDAQ: PMTC]. Before MathSoft, Bill worked for Congoleum Corporation, where he helped structure and raise the capital for its successful $500 million private buyout, and was a CPA in the Boston office of Arthur Andersen & Company.Bill holds an undergraduate degree from Boston College's Carroll School of Management and has served his alma mater in a variety of capacities, including former Chair of the Board of Trustees and current member of its Investment & Endowment Committee. Additionally, Bill has been Chair of the Parents Committee of Duke University and of the Parents Advisory Board of Stanford University, served on the Board of Overseers of Brigham & Women's Hospital and on the advisory boards of Boston Children's Hospital Technology Development Fund, Joslin Diabetes Center, the Center For Connected Health at Partners HealthCare and the Dept. of Biomedical Informatics at Harvard Medical School.Visit www.flarecapital.com to learn more about Flare Capital Partners and reach Bill at bill@flarecapital.com
- Total investments:
- 18
- Last investment:
- Lead investor:
- 28%
Last updated:
For AI agents: llms.txt
Industries Bill Geary invests in
Stages Bill Geary invests in
Countries Bill Geary invests in
Investment Focus
Industry
- Health Care 11 (61%)
- Software 5 (28%)
- Hospital 2 (11%)
- Financial Services 2 (11%)
- Information Technology 2 (11%)
Stage
- Series B 4 (22%)
- Series C 4 (22%)
- Series A 3 (17%)
- Series D 3 (17%)
- Seed 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Suki
|
Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and works with EHR. The company was founded in 2017 and is headquartered in Redwood City, California. | $70M / Series D / Oct 10, 2024 | |
|
Suki
|
Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and works with EHR. The company was founded in 2017 and is headquartered in Redwood City, California. | $55M / Series C / Dec 07, 2021 | |
Aetion
|
Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers.With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about theeffectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson & Johnson Innovation — JJDC, Inc., UCB, and Horizon Health Services, Inc. | $110M / Series C / May 11, 2021 | |
Tausight
|
Tausight’s mission is to solve one of the most challenging responsibilities of healthcare CIOs, CISOs, and their IT organizations: ensuring the confidentiality, integrity, and availability of patients’ PHI. Please visit us at www.tausight.com and follow us on LinkedIn and Twitter. | $20M / Series A / Mar 10, 2021 | |
|
Suki
|
Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and works with EHR. The company was founded in 2017 and is headquartered in Redwood City, California. | $20M / Series B / Mar 04, 2020 | |
Bright Health Group
|
Bright Health Group is built upon the belief that by aligning the best local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, optimize clinical outcomes, reduce systemic waste and lower costs. Our differentiated approach is: Built on Alignment, Focused on the Consumer, and Powered byTechnology. We have two market facing businesses: NeueHealth and Bright HealthCare. Through NeueHealth we deliver high-quality virtual and in-person clinical care to nearly 75,000 unique patients through our 61 affiliated risk-bearing primary care clinics. Through Bright HealthCare we offer Medicare and Commercial health plan products to approximately 623,000 consumers in 14 states and 99 markets. We are making healthcare right. Together. | $635M / Series D / Dec 17, 2019 | |
Neuehealth
|
Bright Health Group is a health insurance company that delivers affordable healthcare to aging and underserved populations. Bright Health aims to improve the healthcare experience by leveraging technology to streamline operations and enhance member engagement. They focus on building partnerships with health systems and care providers to createintegrated healthcare networks. By forming these partnerships, Bright Health seeks to offer its members a more personalized and coordinated healthcare experience.The company differentiates itself by utilizing data analytics and digital tools to help both its members and healthcare providers make more informed decisions about healthcare. They strive to simplify the complexities of health insurance and improve access to quality care for their customers. | $635M / Series D / Dec 17, 2019 | |
|
Aetion
|
Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers.With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about theeffectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson & Johnson Innovation — JJDC, Inc., UCB, and Horizon Health Services, Inc. | $27M / Series B / Feb 05, 2019 | |
|
Bright Health Group
|
Bright Health Group is built upon the belief that by aligning the best local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, optimize clinical outcomes, reduce systemic waste and lower costs. Our differentiated approach is: Built on Alignment, Focused on the Consumer, and Powered byTechnology. We have two market facing businesses: NeueHealth and Bright HealthCare. Through NeueHealth we deliver high-quality virtual and in-person clinical care to nearly 75,000 unique patients through our 61 affiliated risk-bearing primary care clinics. Through Bright HealthCare we offer Medicare and Commercial health plan products to approximately 623,000 consumers in 14 states and 99 markets. We are making healthcare right. Together. | $200M / Series C / Nov 29, 2018 | |
|
Neuehealth
|
Bright Health Group is a health insurance company that delivers affordable healthcare to aging and underserved populations. Bright Health aims to improve the healthcare experience by leveraging technology to streamline operations and enhance member engagement. They focus on building partnerships with health systems and care providers to createintegrated healthcare networks. By forming these partnerships, Bright Health seeks to offer its members a more personalized and coordinated healthcare experience.The company differentiates itself by utilizing data analytics and digital tools to help both its members and healthcare providers make more informed decisions about healthcare. They strive to simplify the complexities of health insurance and improve access to quality care for their customers. | $200M / Series C / Nov 29, 2018 | |
| See all 18 investments → | |||
Co-Investors
About Flare Capital Partners
Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies. The firm invests across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country.
Flare Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Thomas Mac Mahon
Executive Partner
|
|||
Adam Bruce
Chief Financial Officer and Partner
|
|||
|
Bill Geary
Executive Partner Advisor
|
|||
|
Carter Prince
Flare Scholar
|
|||
Chris Kryder
Executive Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bill Geary invest in?
Bill Geary invests primarily in Health Care, Software and Hospital startups, most often at Series B and Series C stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bill Geary last invest?
The most recent investment recorded for Bill Geary closed in Oct 2024. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
